EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 7-Jul-2025 09:10 ET (7-Jul-2025 13:10 GMT/UTC)

Synthetic RIG-I-agonist RNA induces death of hepatocellular carcinoma cells

Mary Ann Liebert, Inc./Genetic Engineering News
Peer-Reviewed Publication

A new study in the peer-reviewed Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I (RIG-I) agonist RNA (RAR) induces innate immune signaling and death of hepatocellular carcinoma cells in vitro.

Journal: Journal of Interferon & Cytokine Research

Data from all 50 states shows early onset breast cancer is on the rise in younger women: Does place of exposure matter?

Columbia University's Mailman School of Public Health
Peer-Reviewed Publication

Breast cancer incidence trends in U.S. women under 40 vary by geography and supports incorporating location information with established risk factors into risk prediction, improving the ability to identify groups of younger women at higher risk for early-onset breast cancer.

Journal: Cancer Causes & Control
Funder: NIH/National Cancer Institute

Cancer cells cooperate to scavenge for nutrients

New York University
Peer-Reviewed Publication

Cancer cells work together to source nutrients from their environment—a cooperative process that was previously overlooked by scientists but may be a promising target for treating cancer.

Journal: Nature
Funder: NIH/National Cancer Institute, American Cancer Society, Pew Charitable Trusts, NIH/National Institutes of Health, New York Stem Cell Foundation, Memorial Sloan Kettering’s Marie-Josée Kravis Women in Science Endeavor

Nerves electrify stomach cancer, sparking growth and spread

Columbia University Irving Medical Center
Peer-Reviewed Publication

Researchers have found, for the first time, that a cancer outside the brain makes electrical connections with the nervous system to fuel cancer growth and aid its spread.

Journal: Nature
Funder: NIH/National Institutes of Health

New sensor can take any gas and tell you what’s in it

University of Colorado at Boulder
Peer-Reviewed Publication

A new laser-based device can scan almost any sample of gas and detect its molecular ingredients down to concentrations in the parts per trillion.

Journal: Nature

Jumbled proteins paint a bold target on the backs of brain tumors

University of California - San Francisco
Peer-Reviewed Publication

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue.

Journal: Nature
Funder: NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health

Rare uterine condition mimics cancer in postmenopausal woman

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — February 19, 2025— A new case report was published in Oncoscience’s Volume 12 on February 10, 2025, titled “Diffuse cystic adenomyosis simulating invasive uterine neoplasm on imaging: A postmenopausal diagnostic perplexity!"

Journal: Oncoscience

Inflammation and metabolic syndrome linked to benign prostatic hyperplasia

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — February 19, 2025 — A new research paper was published by Aging (Aging-US) on January 6, 2025, in Volume 17, Issue 1, titled “The profile of oxidative stress markers (arachidonic and linoleic acid derivatives) in patients with benign prostatic hyperplasia in relation to metabolic syndrome.”

Journal: Aging-US

ASCO GU symposium announces new findings on tumor reduction and survival outcomes in advanced renal cell carcinoma

Texas Tech University Health Sciences Center
Reports and Proceedings

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicineat Texas Tech University Health Sciences Center (TTUHSC) and director of the University Medical Center (UMC) Cancer Center, shared groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in Renal Cell Carcinoma) study. The findings underscore the critical role of tumor size reduction in improving survival outcomes for patients with advanced renal cell carcinoma (aRCC).

Meeting: ASCO Genitourinary (GU) Cancers Symposium

Using light to activate treatments in the right place

Université de Genève
Peer-Reviewed Publication

Acting in the right place at the right time is the key to effective medical treatment with minimal side effects. However, this feat remains difficult to achieve. Biologists and chemists at the University of Geneva (UNIGE) have succeeded in developing a tool that controls the location at which a molecule is activated by a simple pulse of light lasting only a few seconds. Tested on a protein essential for cell division, this system could be applied to other molecules. The potential applications are vast, both in basic research and in improving existing medical treatments, such as those for skin cancer. These results are published in the journal Nature Communications.

Journal: Nature Communications